AC-101

New York, United States, September 20, 2026 IntraBio Inc. has announced that the U.S. Food and Drug Administration (FDA)...

Washington, D.C., September 20, 2026 The Heart Failure Society of America (HFSA) has announced the late-breaking clinical research program...

New York, United States, September 20, 2026 Accro Bioscience has announced that the first patient has been dosed in...